Loading...
Please wait, while we are loading the content...
Similar Documents
Angiographic patterns of restenosis after sirolimus-eluting stent implantation.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Kitahara, Hideki Kobayashi, Yoshio Takebayashi, Hideo Nakamura, Yoshitake Kuroda, Nakabumi Miyazaki, Akira Haruta, Seiichi Komuro, Issei |
| Copyright Year | 2009 |
| Abstract | BACKGROUND Large-scale randomized trials demonstrate a high proportion of focal restenosis after drug-eluting stent (DES) implantation. On the other hand, recent reports have shown that in real-world practice a significant proportion of the restenosis is non-focal when DESs are used in unselected lesions. The present study evaluated angiographic patterns of restenosis after sirolimus-eluting stent (SES) implantation in Japan. METHODS AND RESULTS Angiographic restenosis patterns of all consecutive restenotic lesions (n=124) after SES implantation were evaluated and classified according to the following scheme: focal (10 mm within the stent), proliferative (restenosis >10 mm in length extending outside the stent), and occlusive. There were 98 focal (79.0%), 15 diffuse (12.1%), and 5 proliferative restenoses (4.0%) and 6 total occlusions (4.8%). Focal intrastent restenosis was most dominant (42.7%). Proximal edge restenosis occurred in 22 lesions (17.7%). Multivariate analysis demonstrated diabetes mellitus (P<0.01) as an independent predictor of non-focal restenosis. CONCLUSIONS Focal restenosis is predominant after SES implantation in real-world practice in Japan. |
| Starting Page | 2455 |
| Ending Page | 2460 |
| Page Count | 6 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://www.jstage.jst.go.jp/article/circj/73/3/73_CJ-08-0720/_pdf |
| PubMed reference number | 19151505v1 |
| Volume Number | 73 |
| Issue Number | 3 |
| Journal | Circulation journal : official journal of the Japanese Circulation Society |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Classification Diabetes Mellitus Drug Screening Assays, Antitumor Drug-Eluting Stents Graft Occlusion, Vascular Obstruction Sirolimus Stent Device Component Stent, device restenosis |
| Content Type | Text |
| Resource Type | Article |